Check out our most popular compounded medications! Get Started
Dextromethorphan HBr 100 mg Slow Release Capsules are designed with Methocel E4M, a controlled-release polymer, to gradually release the active ingredient over an extended period. This formulation is used to treat conditions such as cough, bronchitis, asthma, COPD, and allergic rhinitis. The slow release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance, providing long-lasting relief.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dextromethorphan HBr 100 mg Slow Release Capsules is a compounded medication primarily used to alleviate symptoms associated with cough, cold, and flu. As a centrally acting antitussive agent, it functions by suppressing the cough reflex, providing relief from both acute and chronic coughs, as well as other respiratory conditions.
This particular formulation is designed with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period of time. The slow release of the active ingredient, Dextromethorphan HBr, ensures sustained therapeutic effects, reducing the need for frequent dosing. This feature significantly improves patient compliance, especially for those requiring a controlled and prolonged release profile for their medication.
Generally, Dextromethorphan HBr 100 mg Slow Release Capsules are safe and well tolerated by most patients. However, some common side effects may occur, including drowsiness, dizziness, and nausea. Patients are advised to take the medication as directed by their healthcare provider. It is also recommended to avoid activities requiring alertness, such as driving or operating heavy machinery, while on this medication due to its potential side effects.
It is an ideal choice for patients who require a sustained release of the active ingredient for optimal therapeutic effect. For any queries or further information about this formulation, please do not hesitate to contact us at Bayview Pharmacy.
Dextromethorphan HBr 100 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer, designed to gradually release the encapsulated medication over an extended period. This formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
It's important to note that Dextromethorphan HBr 100 mg Slow Release Capsules may interact with other medications. This includes medications used to treat mental health conditions such as depression, anxiety, schizophrenia, bipolar disorder, and others. These medications include selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), and antipsychotics. If you are taking any of these medications, you should not take Dextromethorphan HBr 100 mg Slow Release Capsules.
Additionally, Dextromethorphan HBr 100 mg Slow Release Capsules may interact with medications used to treat other mental health conditions, such as attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and sleep disorders. These medications include stimulants, such as amphetamines and methylphenidate, and sedatives, such as benzodiazepines. If you are taking any of these medications, you should not take Dextromethorphan HBr 100 mg Slow Release Capsules.
Furthermore, Dextromethorphan HBr 100 mg Slow Release Capsules may interact with medications used to treat other medical conditions, such as heart disease, high blood pressure, and diabetes. These medications include beta-blockers, ACE inhibitors, and diuretics. If you are taking any of these medications, you should not take Dextromethorphan HBr 100 mg Slow Release Capsules.
Patients should also be aware that Dextromethorphan HBr 100 mg Slow Release Capsules may interact with medications used to treat pain, such as opioids and nonsteroidal anti-inflammatory drugs (NSAIDs). If you are taking any of these medications, you should not take Dextromethorphan HBr 100 mg Slow Release Capsules.
Moreover, Dextromethorphan HBr 100 mg Slow Release Capsules may interact with medications used to treat allergies, such as antihistamines. If you are taking any of these medications, you should not take Dextromethorphan HBr 100 mg Slow Release Capsules.
Lastly, Dextromethorphan HBr 100 mg Slow Release Capsules may interact with medications used to treat infections, such as antibiotics. If you are taking any of these medications, you should not take Dextromethorphan HBr 100 mg Slow Release Capsules.
If you have any questions about the potential interactions of Dextromethorphan HBr 100 mg Slow Release Capsules, please consult with your healthcare provider.
Dextromethorphan HBr 100 mg Slow Release Capsules are a potent medication designed to alleviate symptoms associated with a variety of respiratory conditions, including cough, cold, flu, allergies, bronchitis, and asthma. The unique slow-release formulation of this medication, which incorporates Methocel E4M, a controlled-release polymer, ensures a gradual and sustained release of the active ingredient, dextromethorphan hydrobromide, into the body over an extended period of time.
This slow-release mechanism offers several benefits. It allows for a more consistent level of the medication in the body, reducing the risk of side effects often associated with fluctuating medication levels. It also offers sustained therapeutic effects, which can help to reduce the severity of symptoms such as sore throat, runny nose, congestion, sneezing, itchy eyes, and other discomforts associated with respiratory illnesses. Furthermore, the reduced dosing frequency improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
It is crucial to take Dextromethorphan HBr 100 mg Slow Release Capsules as directed by your healthcare provider. The dosage and frequency of administration will depend on the specific condition being treated and the individual patient's needs. Always adhere to the instructions on the label and avoid exceeding the recommended dosage to ensure the medication's effectiveness and safety.
If you have any queries about Dextromethorphan HBr 100 mg Slow Release Capsules or how it can help manage your condition, please do not hesitate to reach out to your healthcare provider or pharmacist.
Dextromethorphan HBr 100 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation is designed to gradually release the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly for medications that require a controlled and prolonged release profile.
Chronic pain, fibromyalgia, and irritable bowel syndrome are among the conditions that may benefit from this medication. Symptoms associated with these conditions, such as pain, fatigue, and difficulty sleeping, have been reported to decrease in severity with the use of Dextromethorphan HBr 100 mg Slow Release Capsules.
Furthermore, dextromethorphan has been utilized in the treatment of mental health disorders, including depression and anxiety. It has been found to alleviate symptoms associated with these conditions, such as feelings of sadness, worry, and difficulty concentrating. The medication's potential benefits extend to addiction treatment as well, as it can help reduce cravings and withdrawal symptoms.
It is important to note that the use of dextromethorphan for these conditions should be under the guidance of a healthcare professional. If you have any questions about the use of Dextromethorphan HBr 100 mg Slow Release Capsules for any of these conditions, please consult with your healthcare provider.
Dextromethorphan HBr 100 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
The slow release mechanism works by gradually releasing the encapsulated medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which is designed to control the rate at which the medication is released into the body.
Each capsule contains 100 mg of Dextromethorphan HBr. This dosage is released gradually over an extended period of time due to the controlled-release polymer, Methocel E4M, used in the formulation.
The frequency of dosing will depend on your doctor's instructions. However, the slow release formulation is designed to reduce the need for frequent dosing.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
No, the capsules should not be broken or crushed. Doing so can interfere with the controlled-release mechanism and may result in the entire dose being released at once, which could lead to adverse effects.
Side effects may include dizziness, lightheadedness, drowsiness, stomach upset, nausea, or vomiting. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Before starting this medication, inform your doctor about all the products you use, including prescription drugs, nonprescription drugs, and herbal products. Some products may interact with Dextromethorphan HBr, affecting how it works or increasing the risk for serious side effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
